Skip to main content
Home > Week in Review > Offerings

Chronological Index of : Financial News

 Current Issue
  • Great Basin Corp amends private placement of units

    Great Basin Corp. (NASDAQ:GBSN), Salt Lake City, Utah Business: Diagnostic Date announced: 2015-02-18 Type: Private placement of units To be raised: Up to $15 million Units: 1.3 million Price prior: $2.63 Shares …

    Published on 2/23/2015
  • ACT Genomics completes venture financing

    ACT Genomics Co. Ltd., Taipei City, Taiwan Business: Genomics, Diagnostic, Bioinformatics Date completed: 2015-02-13 Type: Venture financing Raised: $8 million

    Published on 2/23/2015
  • Advaxis Inc completes direct public offering

    Advaxis Inc. (NASDAQ:ADXS), Princeton, N.J. Business: Cancer Date completed: 2015-02-18 Type: Direct public offering Raised: $23 million Shares: 3.1 million Price: $7.50 Shares after offering: 26.7 million Investors: …

    Published on 2/23/2015
  • Angle pl completes placing

    Angle plc (LSE:AGL), Guildford, U.K. Business: Supply/Service, Diagnostic Date completed: 2015-02-16 Type: Placing Raised: 7.3 million ($11.2 million) Shares: 11.2 million Price: 65p Shares after offering: 56.4 million …

    Published on 2/23/2015
  • Check-Cap Ltd completes IPO

    Check-Cap Ltd. (NASDAQ:CHEKU), Isfiya, Israel Business: Diagnostic Date completed: 2015-02-19 Type: IPO Raised: $12 million Shares: 2 million Price: $6 (unit) Shares after offering: 10.1 million Underwriters: Chardan …

    Published on 2/23/2015
  • Check-Cap Ltd completes private placement of units

    Check-Cap Ltd. (NASDAQ:CHEKU), Isfiya, Israel Business: Diagnostic Date completed: 2015-02-19 Type: Private placement of units Raised: $12 million Units: 2 million Price: $6 (unit) Shares after offering: 10.1 million …

    Published on 2/23/2015
  • CollabRx Inc completes follow-on

    CollabRx Inc. (NASDAQ:CLRX), San Francisco, Calif. Business: Bioinformatics Date completed: 2015-02-19 Type: Follow-on Raised: $4.8 million Shares: 3.8 million Price: $1.25 Shares after offering: 6.8 million Underwriter…

    Published on 2/23/2015
  • CombiMatrix Corp completes private placement

    CombiMatrix Corp. (NASDAQ:CBMX), Irvine, Calif. Business: Diagnostic, Microarrays Date completed: 2015-02-13 Type: Private placement Raised: $2.7 million Shares: 1.5 million Price: $1.75 Shares after offering: 12.6 …

    Published on 2/23/2015
  • CombiMatrix Corp completes private placement of units

    CombiMatrix Corp. (NASDAQ:CBMX), Irvine, Calif. Business: Diagnostic, Microarrays Date completed: 2015-02-13 Type: Private placement of units Raised: $2.2 million Units: 2,202 Price: $1,000 (unit) Shares outstanding …

    Published on 2/23/2015
  • Critical Outcome Technologies Inc completes private placement of units

    Critical Outcome Technologies Inc. (TSX-V:COT; OTCQB:COTQF), London, Ontario Business: Cancer, Autoimmune, Infectious Date completed: 2015-02-18 Type: Private placement of units Raised: C$542,990 ($436,510) Units: 2.1 …

    Published on 2/23/2015
  • Inotek Pharmaceuticals Corp completes IPO

    Inotek Pharmaceuticals Corp. (NASDAQ:ITEK), Lexington, Mass. Business: Ophthalmic, Renal, Autoimmune Date completed: 2015-02-18 Type: IPO Raised: $40 million Shares: 6.7 million Price: $6 Shares after offering: 15.9 …

    Published on 2/23/2015
  • Inotek Pharmaceuticals Corp completes private placement of senior convertible notes

    Inotek Pharmaceuticals Corp. (NASDAQ:ITEK), Lexington, Mass. Business: Ophthalmic, Renal, Autoimmune Date completed: 2015-02-18 Type: Private placement of senior convertible notes Raised: $20 million Shares outstanding …

    Published on 2/23/2015
  • Laguna Pharmaceuticals completes venture financing

    Laguna Pharmaceuticals Inc., La Jolla, Calif. Business: Cardiovascular Date completed: 2015-02-17 Type: Venture financing Raised: $30 million Investors: Versant Ventures; Frazier Healthcare; BioMed Ventures; Sante …

    Published on 2/23/2015
  • Lifecode completes venture financing

    Lifecode Inc., Foster City, Calif. Business: Diagnostic, Genomics Date completed: 2015-02-19 Type: Venture financing Raised: $20.5 million Investors: Sequoia Capital; Mayo Clinic

    Published on 2/23/2015
  • Lineagen completes venture financing

    Lineagen Inc., Salt Lake City, Utah Business: Diagnostic, Genomics Date completed: 2015-02-18 Type: Venture financing Raised: $4 million Investor: Silicon Valley Bank Note: The financing is a debt facility.

    Published on 2/23/2015
  • Merganser Biotech completes venture financing

    Merganser Biotech Inc., Newtown Square, Pa. Business: Hematology Date completed: 2015-02-19 Type: Venture financing Raised: $28 million Investors: Novartis Venture Funds; Frazier Healthcare; Sutter Hill Ventures; Osage …

    Published on 2/23/2015
  • Michelson completes venture financing

    Michelson Diagnostics Ltd., Orpington, U.K. Business: Diagnostic Date completed: 2015-02-17 Type: Venture financing Raised: 2.5 million ($3.9 million) Investors: Smith & Nephew plc; Octopus Investments; Kent County …

    Published on 2/23/2015
  • Neurocrine Biosciences Inc completes follow-on

    Neurocrine Biosciences Inc. (NASDAQ:NBIX), San Diego, Calif. Business: Neurology, Cardiovascular, Genitourinary Date completed: 2015-02-19 Type: Follow-on Raised: $287.5 million Shares: 8 million Price: $36 Shares after…

    Published on 2/23/2015
  • NeuroVive Pharmaceutical A completes private placement

    NeuroVive Pharmaceutical AB (SSE:NVP), Lund, Sweden Business: Neurology Date completed: 2015-02-20 Type: Private placement Raised: SEK65 million ($7.7 million) Shares: 1.3 million Price: SEK50 Shares after offering: 29.…

    Published on 2/23/2015
  • Pocared completes venture financing

    Pocared Diagnostics Ltd., Rehovot, Israel Business: Diagnostic Date completed: 2015-02-17 Type: Venture financing Raised: Not disclosed Note: The company closed $15 million in milestone-based funding.

    Published on 2/23/2015
  • Quantum Genomics Corp completes private placement

    Quantum Genomics Corp. (Euronext:ALQGC), Massy, France Business: Cardiovascular Date completed: 2015-02-17 Type: Private placement Raised: EUR11.2 million ($12.8 million) Shares: 1.8 million Price: EUR6.30 Shares after …

    Published on 2/23/2015
  • Signal Genetics Inc completes follow-on

    Signal Genetics Inc. (NASDAQ:SGNL), New York, N.Y. Business: Pharmacogenetics, Diagnostic Date completed: 2015-02-17 Type: Follow-on Raised: $9 million Shares: 3.2 million Price: $2.80 Shares after offering: 7 million …

    Published on 2/23/2015
  • Vaxin completes venture financing

    Vaxin Inc., Rockville, Md. Business: Infectious Date completed: 2015-02-17 Type: Venture financing Raised: $16 million Investors: Novartis Venture Funds; HealthCap; Truffle Capital; Redmont Venture Partners

    Published on 2/23/2015
  • Achillion Pharmaceuticals Inc financial update

    Achillion Pharmaceuticals Inc. (NASDAQ:ACHN), New Haven, Conn. Business: Infectious Date announced: 2015-02-18 Note: Achillion raised $18.5 million through the sale of 1.8 million shares at $10.25 to cover the …

    Published on 2/23/2015
  • Atara Biotherapeutics Inc financial update

    Atara Biotherapeutics Inc. (NASDAQ:ATRA), Brisbane, Calif. Business: Cancer, Renal Date announced: 2015-02-18 Note: Atara raised $9.2 million through the sale of 509,025 shares at $18 to cover the overallotment from its…

    Published on 2/23/2015

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993